Medicaid is the primary payer for long-term supports and services (LTSS) for people with intellectual disabilities and developmental disabilities (I/DD), with expenditures exceeding more than $46 billion annually. As a result, states are challenged to measure the quality of services provided and the outcomes achieved for people receiving LTSS in fee-for-service and managed care programs. This creates pressure on providers on the front lines of service delivery and has the most significant impact on outcomes to substantiate how I/DD supports and services lead to positive results for the people they serve.
Demonstrating value in I/DD services is complex and depends on the measurement of both qualitative and quantitative elements, often focusing on areas that can be difficult to measure, such as quality of life, the extent to which services are reducing costly and preventable poor health outcomes, or how service delivery improves outcomes associated with social determinants of health. And in some cases, there are financial incentives or penalties associated with providers’ ability to demonstrate positive results in these areas.
Join us for this interactive presentation which will:
Provide an overview of I/DD LTSS performance measures and measurement strategies.
Emphasize strategies with the most significant potential for demonstrating value in improving quality of life, promoting health equity, and addressing social determinants of health for people with I/DD.
Throughout the session, which applies to all service providers at all levels of service delivery, participants are encouraged to share their experiences, expertise, and concerns related to I/DD performance measurement.
A recording will be made available for registrants.
Craig Escudé, President, IntellectAbility
Lorene Reagan, Director of Public Relations, IntellectAbility